Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Telma Martins

Showing results (31-40 of 35) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 35 results.
Cancer Immunology, Immunotherapy : CII|January 7, 2010
CD34-based enrichment of genetically engineered human T cells for clinical use results in dramatically enhanced tumor targetingHåkan Norell, Yi Zhang, James McCracken, et al.
Lasers in Medical Science|November 26, 2016
Laser and LED phototherapy on midpalatal suture after rapid maxilla expansion: Raman and histological analysisCristiane Becher Rosa, Fernando Antonio Lima Habib, Telma Martins de Araújo, et al.
Frontiers in Immunology|October 6, 2025
HLA-DR expression in cytotoxic T lymphocytes: a key to boost the therapeutic potential of T cell-based strategies for breast cancerRute Salvador, Bruna Filipa Correia, Daniela Grosa, et al.
Molecular Cancer Therapeutics|March 29, 2012
Off-target function of the Sonic hedgehog inhibitor cyclopamine in mediating apoptosis via nitric oxide-dependent neutral sphingomyelinase 2/ceramide inductionMarisa Meyers-Needham, Jocelyn A Lewis, Salih Gencer, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 17, 2012
A coreceptor-independent transgenic human TCR mediates anti-tumor and anti-self immunity in miceShikhar Mehrotra, Amir A Al-Khami, Jared Klarquist, et al.
Pageof 4

Showing results (31-40 of 35) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 35 results.
Cancer Immunology, Immunotherapy : CII|January 7, 2010
CD34-based enrichment of genetically engineered human T cells for clinical use results in dramatically enhanced tumor targetingHåkan Norell, Yi Zhang, James McCracken, et al.
Lasers in Medical Science|November 26, 2016
Laser and LED phototherapy on midpalatal suture after rapid maxilla expansion: Raman and histological analysisCristiane Becher Rosa, Fernando Antonio Lima Habib, Telma Martins de Araújo, et al.
Frontiers in Immunology|October 6, 2025
HLA-DR expression in cytotoxic T lymphocytes: a key to boost the therapeutic potential of T cell-based strategies for breast cancerRute Salvador, Bruna Filipa Correia, Daniela Grosa, et al.
Molecular Cancer Therapeutics|March 29, 2012
Off-target function of the Sonic hedgehog inhibitor cyclopamine in mediating apoptosis via nitric oxide-dependent neutral sphingomyelinase 2/ceramide inductionMarisa Meyers-Needham, Jocelyn A Lewis, Salih Gencer, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 17, 2012
A coreceptor-independent transgenic human TCR mediates anti-tumor and anti-self immunity in miceShikhar Mehrotra, Amir A Al-Khami, Jared Klarquist, et al.
Pageof 4